Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Sells $120,030.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 3,000 shares of Kewaunee Scientific stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $40.01, for a total transaction of $120,030.00. Following the transaction, the chief financial officer now owns 18,358 shares of the company’s stock, valued at $734,503.58. The trade was a 14.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Kewaunee Scientific Stock Down 5.5 %

Shares of KEQU traded down $2.35 during trading hours on Friday, hitting $40.15. The company had a trading volume of 26,440 shares, compared to its average volume of 22,874. The stock has a market capitalization of $114.63 million, a price-to-earnings ratio of 6.36 and a beta of 0.71. The firm has a fifty day moving average price of $56.22 and a 200-day moving average price of $47.47. Kewaunee Scientific Co. has a 52-week low of $30.82 and a 52-week high of $71.33. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. The business had revenue of $67.17 million during the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Hedge Funds Weigh In On Kewaunee Scientific

A number of hedge funds have recently added to or reduced their stakes in KEQU. Minerva Advisors LLC boosted its stake in Kewaunee Scientific by 4.1% during the 4th quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company’s stock valued at $6,668,000 after purchasing an additional 4,311 shares during the last quarter. Invesco Ltd. bought a new position in shares of Kewaunee Scientific during the fourth quarter valued at $6,545,000. De Lisle Partners LLP boosted its position in shares of Kewaunee Scientific by 36.6% during the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares during the last quarter. American Century Companies Inc. increased its holdings in Kewaunee Scientific by 18.0% in the 4th quarter. American Century Companies Inc. now owns 34,293 shares of the technology company’s stock worth $2,122,000 after buying an additional 5,221 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC raised its position in Kewaunee Scientific by 3.3% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock worth $1,733,000 after buying an additional 891 shares during the last quarter. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday, March 14th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.